Send the following on WhatsApp
Continue to ChatFDA restricts GSK’s Xevudy due to lower efficacy against BA.2 https://invesbrain.com/fda-restricts-gsks-xevudy-due-to-lower-efficacy-against-ba-2/
FDA restricts GSK’s Xevudy due to lower efficacy against BA.2 https://invesbrain.com/fda-restricts-gsks-xevudy-due-to-lower-efficacy-against-ba-2/